Stewardship of Off-Label Treatments for COVID-19 (ASHP)
A general guide for prescribers, pharmacists, and patients when considering the appropriate use of experimental treatments. These especially include azithromycin, chloroquine, and hydroxychloroquine, but also include baloxavir, lopinavir and ritonavir, oseltamivir, remdesivir, sarilumab, tocilizumab, and sirolimus.